ArticleThe oncologist2025
Correction to: Association between sidedness and survival among chemotherapy refractory metastatic colorectal cancer patients treated with trifluridine/tipiracil or regorafenib.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.